Transparency Market Research Report Added "Hormone Replacement Therapy Market" to its database.
Albany, NY -- (SBWIRE) -- 03/04/2016 -- Transparency Market Research, a reputed research company, offers a thoroughly researched report about the global hormone replacement therapy market. The research report, titled "Hormone Replacement Therapy Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 – 2018," details the important elements influencing the trajectory of the market. Furthermore, it also uses market measurement tools such as SWOT analysis and Porter's five forces analysis to determine the strengths, weaknesses, opportunities, and threats and the threats from new entrants, the threat of substitute products or services, the bargaining power of customers, the bargaining power of suppliers, and the intensity of competitive rivalry in the market. Additionally, expert industry analysts have also studied this market from a political, economic, social, technological, legal, and environmental point of view to provide a holistic outlook of the global hormone replacement therapy market.
Hormone replacement therapy (HRT) refers to helping patients suffering from declining levels of hormones with the right administration of hormones into the body. These therapies are generally meted out to women undergoing menopause. Estrogen is among the most commonly administered hormones. However, progesterone and testosterone are also administered when needed. These hormones are administered through implants, oral tables, vaginal creams, and patches, amongst others.
For More Information: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=610
According to the research report, the global hormone replacement therapy market is segmented into estrogen replacement therapy, thyroid hormone replacement therapy, and growth hormone replacement therapy. Currently, the estrogen replacement therapy segment holds the largest share in the global hormone replacement therapy market. The largest consumers of estrogen replacement therapy are post-menopausal women. Growth hormone therapy is used for children, while thyroid replacement therapies are applied to elderly people.
The key growth driver of the global hormone replacement therapy market is the increasing awareness about post-menopausal problems amongst women. The other noteworthy growth drivers are the emergence of innovative drug delivery methods and the unmet needs in Asian markets. Geographically, North America holds the largest share in the global hormone replacement therapy market due to its developed economy and increasing purchasing power of patients.
Some of the key players profiled in the global hormone Noven Pharmaceuticals, Amgen, Pfizer, BioSante Pharmaceuticals, and Merck & co., QuatRx Pharmaceuticals, and Depomed Inc., amongst others. The research report details the competitive landscape of the global hormone replace therapy market by analyzing the key market drivers and restraints and the impact of the regulatory framework. The research report also offers an insightful take on the financial overview, research and development activities, business and marketing strategies, product portfolio, and strategic mergers and acquisitions of these top players.
Mr. Sudip S
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453